Search tips
Search criteria 


Logo of molcellbPermissionsJournals.ASM.orgJournalMCB ArticleJournal InfoAuthorsReviewers
Mol Cell Biol. 1982 November; 2(11): 1410–1416.
PMCID: PMC369945

Modulation of the Plasminogen Activator Activity of a Transformed Cell Line by Cell Density


The effects of variations in cell density on the expression of the plasminogen activator activity of a tumorigenic rat cell line were analyzed. At low cell densities, the plasminogen activator activity per cell was high and independent of cell density. As the cell density increased, the plasminogen activator activity per cell decreased until it eventually became inversely proportional to cell density. Inhibition of the plasminogen activator activity per cell by increases in cell density was not the result of the presence of a soluble inhibitor but seemed to require cell-to-cell contact. The Vmax per cell for the activation of plasminogen changed at high cell densities, but the Km did not change. This change in the Vmax per cell was in part the result of a change in the catalytic rate constant for the conversion of plasminogen to plasmin. This was inferred from studies on the kinetics of inhibition of plasminogen activator activity by diisopropyl fluorophosphate as a function of cell density. For cells growing at high densities, the rate of inhibition was constant, exhibiting a second-order rate constant of 2.6 × 10−2M−1 s−1. For cells growing at low densities, the plasminogen activator activity was inhibited at two different rates, one exhibiting a second-order rate constant of 2.6 × 10−2M−1 s−1 and the other exhibiting a second-order rate constant of 9.4 × 10−2M−1 s−1. We discuss the importance of cell density in assays of the plasminogen activator activity of cells, the use of this cell line to study the biochemical basis of the density dependence of plasminogen activator activity, and the density-dependent role of plasminogen activator activity in tumor formation and metastasis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bernik MB, Kwaan HC. Origin of fibrinolytic activity in cultures of the human kidney. J Lab Clin Med. 1967 Oct;70(4):650–661. [PubMed]
  • Bernik MB, Kwaan HC. Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study. J Clin Invest. 1969 Sep;48(9):1740–1753. [PMC free article] [PubMed]
  • Castellino FJ, Sodetz JM. Rabbit plasminogen and plasmin isozymes. Methods Enzymol. 1976;45:273–286. [PubMed]
  • Chou IN, O'Donnell SP, Black PH, Roblin RO. Cell density-dependent secretion of plasminogen activator by 3T3 cells. J Cell Physiol. 1977 Apr;91(1):31–37. [PubMed]
  • Christman JK, Silagi S, Newcomb EW, Silverstein SC, Acs G. Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells. Proc Natl Acad Sci U S A. 1975 Jan;72(1):47–50. [PubMed]
  • Cleland WW. The statistical analysis of enzyme kinetic data. Adv Enzymol Relat Areas Mol Biol. 1967;29:1–32. [PubMed]
  • Gallimore PH, McDougall JK, Chen LB. In vitro traits of adenovirus-transformed cell lines and their relevance to tumorigenicity in nude mice. Cell. 1977 Apr;10(4):669–678. [PubMed]
  • Imada M, Sueoka N. Clonal sublines of rat neurotumor RT4 and cell differentiation. I. Isolation and characterization of cell lines and cell type conversion. Dev Biol. 1978 Sep;66(1):97–108. [PubMed]
  • Imada M, Sueoka N, Rifkin DB. Clonal sublines of rat neurotumor RT4 and cell differentiation. II. A conversion coupling of tumorigenicity and a glial property. Dev Biol. 1978 Sep;66(1):109–116. [PubMed]
  • Leytus SP, Peltz GA, Liu HY, Cannon JF, Peltz SW, Livingston DC, Brocklehurst JR, Mangel WF. A quantitative assay for the activation of plasminogen by transformed cells in situ and by urokinase. Biochemistry. 1981 Jul 21;20(15):4307–4314. [PubMed]
  • Liu HY, Peltz GA, Leytus SP, Livingston C, Brocklehurst J, Mangel WF. Sensitive assay for plasminogen activator of transformed cells. Proc Natl Acad Sci U S A. 1980 Jul;77(7):3796–3800. [PubMed]
  • Marshall CJ, Franks LM, Carbonell AW. Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas. J Natl Cancer Inst. 1977 Jun;58(6):1743–1751. [PubMed]
  • Ossowski L, Quigley JP, Kellerman GM, Reich E. Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration. J Exp Med. 1973 Nov 1;138(5):1056–1064. [PMC free article] [PubMed]
  • Ossowski L, Biegel D, Reich E. Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell. 1979 Apr;16(4):929–940. [PubMed]
  • Ossowski L, Reich E. Experimental model for quantitative study of metastasis. Cancer Res. 1980 Jul;40(7):2300–2309. [PubMed]
  • Ossowski L, Reich E. Loss of malignancy during serial passage of human carcinoma in culture and discordance between malignancy and transformation parameters. Cancer Res. 1980 Jul;40(7):2310–2315. [PubMed]
  • Peltz SW, Hardt TA, Mangel WF. Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids. Biochemistry. 1982 May 25;21(11):2798–2804. [PubMed]
  • Pollack R, Risser R, Conlon S, Rifkin D. Plasminogen activator production accompanies loss of anchorage regulation in transformation of primary rat embryo cells by simian virus 40. Proc Natl Acad Sci U S A. 1974 Dec;71(12):4792–4796. [PubMed]
  • Rohrlich ST, Rifkin DB. Patterns of plasminogen activator production in cultured normal embryonic cells. J Cell Biol. 1977 Oct;75(1):31–42. [PMC free article] [PubMed]
  • Stiles CD, Desmond W, Chuman LM, Sato G, Saier MH., Jr Relationship of cell growth behavior in vitro to tumorigenicity in athymic nude mice. Cancer Res. 1976 Sep;36(9 PT1):3300–3305. [PubMed]
  • Unkeless JC, Gordon S, Reich E. Secretion of plasminogen activator by stimulated macrophages. J Exp Med. 1974 Apr 1;139(4):834–850. [PMC free article] [PubMed]
  • Unkeless JC, Tobia A, Ossowski L, Quigley JP, Rifkin DB, Reich E. An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med. 1973 Jan 1;137(1):85–111. [PMC free article] [PubMed]
  • Wiman B, Collen D. Molecular mechanism of physiological fibrinolysis. Nature. 1978 Apr 6;272(5653):549–550. [PubMed]
  • Wolf BA, Goldberg AR. Rous-sarcoma-virus-transformed fibroblasts having low levels of plasminogen activator. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3613–3617. [PubMed]

Articles from Molecular and Cellular Biology are provided here courtesy of American Society for Microbiology (ASM)